News18» News»World»Coronavirus Trial Drug Remdesivir's Maker Gilead Hopes for Swift FDA Approval, Says CEO
1-MIN READ

Coronavirus Trial Drug Remdesivir's Maker Gilead Hopes for Swift FDA Approval, Says CEO

Image for representation.

Image for representation.

It would try to get the drug to as many people as possible if it was approved, he said.

The chief executive of Gilead Sciences Inc, maker of the experimental coronavirus drug remdesivir, said on Friday he expected the Food and Drug Administration to act quickly over the company's application for approval.

It would try to get the drug to as many people as possible if it was approved, he said.

"We're moving very quickly with the FDA," Daniel O'Day said in an interview with NBC's Today show. "And I expect that they're going to act very quickly."